Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

33.22
-0.1186-0.36%
Volume:3K
Turnover:85.60K
Market Cap:32.39M
PE:- -
High:33.32
Open:33.32
Low:33.08
Close:33.34
52wk High:36.72
52wk Low:27.57
Shares:975.00K
Float Shares:975.00K
Volume Ratio:0.35
T/O Rate:0.26%
Dividend:0.16
Dividend Rate:0.49%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Reuters
·
16 mins ago

Nurix Extends Gilead Collaboration for Oncology Program

Reuters
·
16 mins ago

Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026

THOMSON REUTERS
·
20 mins ago

Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties

THOMSON REUTERS
·
20 mins ago

Nurix - to Receive $10 Mln Research Term Extension Fee

THOMSON REUTERS
·
20 mins ago

Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs

THOMSON REUTERS
·
20 mins ago

Eli Lilly & Co (LLY) Gets a Buy from RBC Capital

TIPRANKS
·
Oct 03

Abbott Laboratories (ABT) Launches SimpleScreen CRC As Fair Value Debate Heats Up

Simply Wall St.
·
Oct 03

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 03

Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares

Reuters
·
Oct 03

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Oct 03

Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million

Dow Jones
·
Oct 03

Eli Lilly announces FDA approves additional indication for Jaypirca

TIPRANKS
·
Oct 03

Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca

Reuters
·
Oct 03

Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll

THOMSON REUTERS
·
Oct 03

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live
·
Oct 03

Correction: Top Midday Decliners

MT Newswires Live
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)

TIPRANKS
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Corbion CEO Olivier Rigaud to Step Down in 2027

Reuters
·
Oct 02